The acquisition strengthens our integrated capabilities, including patient services, HEOR, RWE generation, and adherence strategy. This complements our best-in-class medical affairs, commercialization, access, and oncology education offerings for life sciences organizations.

此次收购增强了我们的综合能力，包括患者服务、卫生经济学与结果研究（HEOR）、真实世界证据（RWE）生成以及依从性策略。这与我们为生命科学机构提供的业内领先的医学事务、商业化、准入和肿瘤学教育服务相辅相成。

STAMFORD, Conn.

康涅狄格州斯坦福市

,

，

March 17, 2026

2026年3月17日

/PRNewswire/ -- Nexus Health, a strategic consulting and market access firm and part of The Lockwood Group, today announced the acquisition of Stratis Group, a consulting firm specializing in commercialization strategy, market access, patient services, HEOR, field reimbursement management (FRM), and analytics for pharmaceutical, biotechnology, and physician network clients.

/PRNewswire/ -- Nexus Health，一家战略咨询和市场准入公司，同时也是The Lockwood Group的一部分，今天宣布收购Stratis Group，这是一家专注于商业化战略、市场准入、患者服务、卫生经济学与结果研究（HEOR）、现场报销管理（FRM）以及为制药、生物技术和医师网络客户提供分析服务的咨询公司。

The acquisition strengthens Nexus Health's ability to deliver integrated, data-driven solutions that support clients from early commercialization planning through launch and lifecycle optimization..

此次收购增强了Nexus Health提供集成的、数据驱动的解决方案的能力，这些方案支持客户从早期商业化规划到上市及生命周期优化的全过程。

'Joining forces with Nexus Health and The Lockwood Group allows Stratis to scale market access solutions quicker than we could as a standalone organization,' said

“与Nexus Health和The Lockwood Group联手，使Stratis能够比作为独立组织更快地扩展市场准入解决方案，”

Casey Cormier,

凯西·科米耶，

Principal & Co-Founder, Stratis Group

首席执行官兼联合创始人，Stratis集团

.

。

Joe Musumeci,

乔·穆苏梅奇，

Principal & Co-Founder, Stratis Group

首席执行官兼联合创始人，Stratis集团

also commented that, 'Our shared vision of science-driven, client-centered solutions will deliver greater strategic value to clients and help ensure better patient outcomes in an increasingly complex health care landscape.'

还评论道：“我们以科学为驱动、以客户为中心的解决方案的共同愿景，将为客户带来更大的战略价值，并帮助确保在日益复杂的医疗环境中取得更好的患者治疗效果。”

'We're thrilled to welcome Casey, Joe, and the entire Stratis team to Nexus Health,' said

“我们非常高兴欢迎Casey、Joe以及整个Stratis团队加入Nexus Health，”

Andrew Gottfried, CEO, Nexus Health

安德鲁·戈特弗里德，Nexus Health首席执行官

. 'Stratis has built a reputation for deep strategic expertise and nimble execution across commercialization and market access challenges. This acquisition expands our integrated service offerings through deep quantitative analytics and strengthens our ability to partner with life sciences organizations at every stage of product development, launch, and growth.'.

“Stratis凭借在商业化和市场准入挑战方面的深厚战略专业知识和敏捷执行能力建立了声誉。此次收购通过深入的定量分析扩展了我们的综合服务范围，并增强了我们在产品开发、上市和增长的每个阶段与生命科学组织合作的能力。”

Matthew Schecter, Founder & CEO, The Lockwood Group

马修·谢克特，创始人兼首席执行官，洛克伍德集团

also commented, 'With the addition of Stratis, we are further strengthening our market access platform and expanding the strategic capabilities we can deliver to life sciences clients. Under Andrew's leadership, Nexus Health has built strong momentum over the past year.'

还评论道：“随着Stratis的加入，我们将进一步加强我们的市场准入平台，并扩展我们能够为生命科学客户提供的战略能力。在Andrew的领导下，Nexus Health在过去一年中建立了强大的动力。”

Founded in 2014, Stratis Group brings a unique approach to commercialization, combining advanced analytics, customer research, and market insights to inform strategy and optimize outcomes. Stratis' service portfolio includes forecasting and epidemiology, patient support services, field reimbursement staffing, brand analytics, market access optimization, data insights, and organizational development—complementing and augmenting Nexus' existing capabilities..

Stratis Group 成立于2014年，采用独特的商业化方法，结合高级分析、客户研究和市场洞察来指导战略并优化成果。Stratis 的服务组合包括预测与流行病学、患者支持服务、现场报销人员配置、品牌分析、市场准入优化、数据洞察以及组织发展——这些都对 Nexus 的现有能力形成了补充和增强。

The acquisition aligns with The Lockwood Group's ongoing growth strategy, which includes expanding market access and commercialization support services. In recent years, Nexus Health has broadened its service offerings to include strategic consulting, value communications, and patient access and affordability solutions..

此次收购符合洛克伍德集团持续增长的战略，该战略包括扩大市场准入和商业化支持服务。近年来，Nexus Health拓宽了其服务范围，涵盖战略咨询、价值沟通以及患者准入和支付能力解决方案。

Clearsight Advisors served as the exclusive financial advisor, and Pillsbury Winthrop Shaw Pittman LLP served as legal counsel to Stratis.

Clearsight Advisors 担任独家财务顾问，Pillsbury Winthrop Shaw Pittman LLP 担任 Stratis 的法律顾问。

About Stratis Group

关于Stratis集团

Stratis Group is a commercialization strategy and consulting firm headquartered in Palm Beach Gardens, FL, serving clients across pharmaceutical, biotechnology, and academic sectors. Stratis combines rigorous analytics, customer insight, and tailored strategic guidance to support product commercialization, market access, and long-term brand success.

斯特拉蒂斯集团是一家总部位于佛罗里达州棕榈滩花园的商业化战略和咨询公司，服务于制药、生物技术和学术领域的客户。斯特拉蒂斯结合严格的分析、客户洞察和定制的战略指导，支持产品的商业化、市场准入以及品牌的长期成功。

For more information, visit .

欲了解更多信息，请访问 。

www.stratisgrp.com

www.stratisgrp.com

.

。

About Nexus Health

关于Nexus Health

Nexus Health, part of The Lockwood Group, provides integrated market access and commercialization strategies to help life science companies successfully launch, differentiate, and grow their products in competitive environments. Nexus combines deep market access experience with analytical rigor and strategic insight to deliver solutions that improve reimbursement outcomes, increase patient access, and accelerate product adoption.

Nexus Health是The Lockwood Group的一部分，为生命科学公司提供整合的市场准入和商业化策略，帮助他们在竞争激烈的环境中成功推出、差异化并发展其产品。Nexus结合深厚的市场准入经验、严谨的分析能力和战略洞察，提供改善报销结果、增加患者获取机会并加速产品采用的解决方案。

For more information, visit .

欲了解更多信息，请访问 。

www.nexushealthgrp.com

www.nexushealthgrp.com

.

。

About The Lockwood Group

关于洛克伍德集团

The Lockwood Group is a leading provider of scientific-based medical communications and commercialization consulting services. Through its portfolio of specialized companies, Lockwood supports pharmaceutical, biotechnology, and medical device manufacturers with integrated services that enhance scientific engagement, support successful product commercialization, and maximize portfolio value.

洛克伍德集团是基于科学的医学传播和商业化咨询领域的领先提供商。通过其专业公司的组合，洛克伍德为制药、生物技术和医疗器械制造商提供综合服务，以加强科学交流、支持产品成功商业化并最大化产品组合价值。

For more information, visit .

欲了解更多信息，请访问 。

www.thelockwoodgrp.com

www.thelockwoodgrp.com

.

。

Media Contacts:

媒体联系人：

For Nexus Health Group & The Lockwood Group:

对于Nexus健康集团和Lockwood集团：

Michelle Maskaly

米歇尔·马斯卡利

[email protected]

电子邮件地址

SOURCE Nexus Health

来源：Nexus Health

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示